- call +1-201-465-4211
- email sales@mrinsights.biz
Biological therapy consists of using a living organism substance derived either from living organisms or laboratory produced variations of the substances to treat a particular disease. Biological therapies generally comprise interleukins, interferons, monoclonal antibodies, vaccines and so on. Biological therapy utilizes the body’s immune system either directly or indirectly in order to fight cancer. Some biological therapies for cancer use vaccines or bacteria to stimulate the body’s immune system to act against cancer cells where as some therapies involve antibodies.
Scope of the Report:
North America dominates a major share of the global Cancer Biological Therapy market
On the other hand, Asia pacific is projected to develop at a highest rate owing to growingoccurrence of cancer, large patient pool, improving healthcare facilities, etc.
The worldwide market for Cancer Biological Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Cancer Biological Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors
Market Segment by Applications, can be divided into
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
There are 15 Chapters to deeply display the global Cancer Biological Therapy market.
Chapter 1, to describe Cancer Biological Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cancer Biological Therapy, with sales, revenue, and price of Cancer Biological Therapy, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Biological Therapy, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cancer Biological Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cancer Biological Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cancer Biological Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal Antibodies
1.2.2 Vaccines
1.2.3 Cancer Growth Blockers
1.2.4 Blood Cell Growth Factors
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Diagnostic Laboratories
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ELI Lilly
2.1.1 Business Overview
2.1.2 Cancer Biological Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ELI Lilly Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Cancer Biological Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Cancer Biological Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Cancer Biological Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche
2.5.1 Business Overview
2.5.2 Cancer Biological Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis International
2.6.1 Business Overview
2.6.2 Cancer Biological Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis International Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Cancer Biological Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 Cancer Biological Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Seattle Genetics
2.9.1 Business Overview
2.9.2 Cancer Biological Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Seattle Genetics Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Amgen
2.10.1 Business Overview
2.10.2 Cancer Biological Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Amgen Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Takeda Pharmaceuticals
2.11.1 Business Overview
2.11.2 Cancer Biological Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 GlaxoSmithKline
2.12.1 Business Overview
2.12.2 Cancer Biological Therapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 GlaxoSmithKline Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Spectrum Pharmaceuticals
2.13.1 Business Overview
2.13.2 Cancer Biological Therapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Celgene Corporation
2.14.1 Business Overview
2.14.2 Cancer Biological Therapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Celgene Corporation Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 AstraZeneca, Plc.
2.15.1 Business Overview
2.15.2 Cancer Biological Therapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 AstraZeneca, Plc. Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Otsuka
2.16.1 Business Overview
2.16.2 Cancer Biological Therapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Otsuka Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Eisai
2.17.1 Business Overview
2.17.2 Cancer Biological Therapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Eisai Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Abbvie
2.18.1 Business Overview
2.18.2 Cancer Biological Therapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Abbvie Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Incyte
2.19.1 Business Overview
2.19.2 Cancer Biological Therapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Incyte Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Biological Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cancer Biological Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cancer Biological Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Biological Therapy Manufacturer Market Share in 2017
3.3.2 Top 6 Cancer Biological Therapy Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cancer Biological Therapy Market Analysis by Regions
4.1 Global Cancer Biological Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Biological Therapy Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cancer Biological Therapy Revenue and Market Share by Regions (2013-2018)
4.2 North America Cancer Biological Therapy Sales and Growth Rate (2013-2018)
4.3 Europe Cancer Biological Therapy Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Biological Therapy Sales and Growth Rate (2013-2018)
4.5 South America Cancer Biological Therapy Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Biological Therapy Sales and Growth Rate (2013-2018)
5 North America Cancer Biological Therapy by Countries
5.1 North America Cancer Biological Therapy Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Biological Therapy Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cancer Biological Therapy Revenue and Market Share by Countries (2013-2018)
5.2 United States Cancer Biological Therapy Sales and Growth Rate (2013-2018)
5.3 Canada Cancer Biological Therapy Sales and Growth Rate (2013-2018)
5.4 Mexico Cancer Biological Therapy Sales and Growth Rate (2013-2018)
6 Europe Cancer Biological Therapy by Countries
6.1 Europe Cancer Biological Therapy Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Biological Therapy Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cancer Biological Therapy Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cancer Biological Therapy Sales and Growth Rate (2013-2018)
6.3 UK Cancer Biological Therapy Sales and Growth Rate (2013-2018)
6.4 France Cancer Biological Therapy Sales and Growth Rate (2013-2018)
6.5 Russia Cancer Biological Therapy Sales and Growth Rate (2013-2018)
6.6 Italy Cancer Biological Therapy Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Biological Therapy by Countries
7.1 Asia-Pacific Cancer Biological Therapy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Biological Therapy Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cancer Biological Therapy Revenue and Market Share by Countries (2013-2018)
7.2 China Cancer Biological Therapy Sales and Growth Rate (2013-2018)
7.3 Japan Cancer Biological Therapy Sales and Growth Rate (2013-2018)
7.4 Korea Cancer Biological Therapy Sales and Growth Rate (2013-2018)
7.5 India Cancer Biological Therapy Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Biological Therapy Sales and Growth Rate (2013-2018)
8 South America Cancer Biological Therapy by Countries
8.1 South America Cancer Biological Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Biological Therapy Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cancer Biological Therapy Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cancer Biological Therapy Sales and Growth Rate (2013-2018)
8.3 Argentina Cancer Biological Therapy Sales and Growth Rate (2013-2018)
8.4 Colombia Cancer Biological Therapy Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cancer Biological Therapy by Countries
9.1 Middle East and Africa Cancer Biological Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Biological Therapy Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cancer Biological Therapy Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cancer Biological Therapy Sales and Growth Rate (2013-2018)
9.3 UAE Cancer Biological Therapy Sales and Growth Rate (2013-2018)
9.4 Egypt Cancer Biological Therapy Sales and Growth Rate (2013-2018)
9.5 Nigeria Cancer Biological Therapy Sales and Growth Rate (2013-2018)
9.6 South Africa Cancer Biological Therapy Sales and Growth Rate (2013-2018)
10 Global Cancer Biological Therapy Market Segment by Type
10.1 Global Cancer Biological Therapy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cancer Biological Therapy Sales and Market Share by Type (2013-2018)
10.1.2 Global Cancer Biological Therapy Revenue and Market Share by Type (2013-2018)
10.2 Monoclonal Antibodies Sales Growth and Price
10.2.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.2.2 Global Monoclonal Antibodies Price (2013-2018)
10.3 Vaccines Sales Growth and Price
10.3.1 Global Vaccines Sales Growth (2013-2018)
10.3.2 Global Vaccines Price (2013-2018)
10.4 Cancer Growth Blockers Sales Growth and Price
10.4.1 Global Cancer Growth Blockers Sales Growth (2013-2018)
10.4.2 Global Cancer Growth Blockers Price (2013-2018)
10.5 Blood Cell Growth Factors Sales Growth and Price
10.5.1 Global Blood Cell Growth Factors Sales Growth (2013-2018)
10.5.2 Global Blood Cell Growth Factors Price (2013-2018)
11 Global Cancer Biological Therapy Market Segment by Application
11.1 Global Cancer Biological Therapy Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Diagnostic Laboratories Sales Growth (2013-2018)
11.4 Research & Academic Laboratories Sales Growth (2013-2018)
11.5 Pharmaceutical & Biotechnology Companies Sales Growth (2013-2018)
12 Cancer Biological Therapy Market Forecast (2018-2023)
12.1 Global Cancer Biological Therapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Cancer Biological Therapy Market Forecast by Regions (2018-2023)
12.2.1 North America Cancer Biological Therapy Market Forecast (2018-2023)
12.2.2 Europe Cancer Biological Therapy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cancer Biological Therapy Market Forecast (2018-2023)
12.2.4 South America Cancer Biological Therapy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cancer Biological Therapy Market Forecast (2018-2023)
12.3 Cancer Biological Therapy Market Forecast by Type (2018-2023)
12.3.1 Global Cancer Biological Therapy Sales Forecast by Type (2018-2023)
12.3.2 Global Cancer Biological Therapy Market Share Forecast by Type (2018-2023)
12.4 Cancer Biological Therapy Market Forecast by Application (2018-2023)
12.4.1 Global Cancer Biological Therapy Sales Forecast by Application (2018-2023)
12.4.2 Global Cancer Biological Therapy Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cancer Biological Therapy Picture
Table Product Specifications of Cancer Biological Therapy
Figure Global Sales Market Share of Cancer Biological Therapy by Types in
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
